Skip to main content
Premium Trial:

Request an Annual Quote

Teranode Design Suite 2, GenBank release 144.0, HapMap data release 12, IBM Solution for Compliance in a Regulated Environment (SCORE)

Premium

Teranode has released three new products: Teranode Design Suite 2, a “closed-loop” R&D platform for integrating modeling into existing informatics infrastructures; Teranode Model Server, which provides a single repository for managing design through protocol development and experimentation to evaluation; and the Teranode Accelerator Development Kit, which contains an application programming interface, a library of existing integrations, and documentation.


GenBank release 144.0 is now available via ftp from the National Center for Biotechnology Information at ftp://ftp.ncbi.nih.gov/. The release contains 43,194,602,655 base pairs and 38,941,263 entries, up by 1,386,557,002 base pairs and by 1,597,326 sequence records (non-WGS) and 2,742,978,532 base pairs and by 857,503 sequence records (WGS) from the August 143.0 release. Uncompressed, the 144.0 flat files require about 147 GB for the sequence files only. The ASN.1 version requires around 128 GB.


HapMap data release 12 is now available from the HapMap Data Coordination Center at Cold Spring Harbor Laboratory at http://www.hapmap.org. The release contains 752,208 genotype sets from the 90 CEPH-panel samples, totaling 67,698,720 genotypes, according to the organization.


IBM Healthcare and Life Sciences said they have launched the IBM Solution for Compliance in a Regulated Environment (SCORE). The technology is designed as a regulatory compliance system to help pharmaceutical, biotechnology, and medical device companies comply with regulatory mandates for R&D, manufacturing, and sales and marketing processes.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.